Načítá se...
FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations
Internal tandem duplications of the FMS-like tyrosine kinase 3 (FLT3) gene are one of the most frequent gene mutations in acute myeloid leukemia (AML) and are associated with poor clinical outcome. The remission rate is high with intensive chemotherapy, but most patients eventually relapse. During t...
Uloženo v:
| Vydáno v: | Leuk Lymphoma |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4333682/ https://ncbi.nlm.nih.gov/pubmed/23631653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.800198 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|